Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 17.50
0.00 (0.00%)
At close: Jan 30, 2026
Bio-View Market Cap
Bio-View has a market cap or net worth of 23.45 million as of January 30, 2026. Its market cap has decreased by -37.62% in one year.
Market Cap
23.45M
Enterprise Value
17.47M
Revenue
17.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.50
Market Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 23.45M, a decrease of -60.78%. That is a compound annual growth rate of -4.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 23.45M | 4.79% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.12B |
| Danel (Adir Yeoshua) | 2.80B |
| BrainsWay | 1.52B |
| Kamada | 1.50B |
| Evogene | 28.50M |
| Nextage Therapeutics | 26.25M |
| XTL Biopharmaceuticals | 25.55M |
| Identi Healthcare | 25.39M |